Sanofi

Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Fierce Pharma
Sanofi
Lantus
Eli Lilly
Boehringer Ingelheim
Mylan Labs
generics
diabetes
insulin
basal insulin
Flag link:
Sanofi to Cut 670 Jobs in France by 2020
Sanofi to Cut 670 Jobs in France by 2020
BioSpace
Sanofi
France
layoffs
Flag link:
Sanofi merges biology and tech with research deal for digital asthma lab
Sanofi merges biology and tech with research deal for digital asthma lab
Fierce Pharma
Sanofi
asthma
artificial intelligence
technology
Sema4
Flag link:
FDA hits Sanofi's struggling Lemtrada with new safety warning over reports of stroke, artery tears
FDA hits Sanofi's struggling Lemtrada with new safety warning over reports of stroke, artery tears
Fierce Pharma
Sanofi
Lemtrada
FDA
stroke
MS
Flag link:
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
BioSpace
GSK
JNJ
Novartis
Merck KGaA
Sanofi
Takeda
developing countries
Flag link:
Sanofi teams with non-profit on a landmark new drug for sleeping sickness
Sanofi teams with non-profit on a landmark new drug for sleeping sickness
Endpoints
EMA
Sanofi
fexinidazole
sleeping sickness
Flag link:
7 drugs that raised eyebrows in Q3
7 drugs that raised eyebrows in Q3
Biopharma Dive
Sanofi
Dupixent
Roche
Herceptin
AbbVie
Humira
Regeneron
Repatha
Clovis Oncology
Rubraca
GSK
Shingrix
Eli Lilly
Trulicity
Flag link:
Going gangbusters in atopic dermatitis, the FDA hands Sanofi and Regeneron a fresh coup for their mega-blockbuster star Dupixent
Going gangbusters in atopic dermatitis, the FDA hands Sanofi and Regeneron a fresh coup for their mega-blockbuster star Dupixent
Endpoints
Sanofi
Regeneron
Dupixent
atopic dermatitis
Flag link:
Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs
Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs
Xconomy
Sanofi
Denali Therapeutics
inflammation
Alzheimer's disease
R&D
Flag link:
Digital diabetes mavens Novo Nordisk and Sanofi top new patient experience ranking
Digital diabetes mavens Novo Nordisk and Sanofi top new patient experience ranking
Fierce Pharma
patients
patient experience data
Sanofi
Novo Nordisk
type 2 diabetes
Flag link:
Sanofi drug Dupixent wins U.S. FDA approval to treat asthma
Sanofi drug Dupixent wins U.S. FDA approval to treat asthma
Yahoo/Reuters
Sanofi
asthma
FDA
Dupixent
Flag link:
Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices
Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices
Biopharma Dive
Minnesota
insulin
diabetes
PBMs
Sanofi
Novo Nordisk
Eli Lilly
Flag link:
Sanofi, Genentech Both Eye U.S. Expansions; Could Add up to 2,300 Jobs
Sanofi, Genentech Both Eye U.S. Expansions; Could Add up to 2,300 Jobs
BioSpace
Sanofi
Cambridge MA
Genentech
Oregon
Flag link:
Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII
Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII
Endpoints
Regeneron
Sanofi
Dupixent
nasal polyps
rhinosinusitis
Flag link:
Can Sanofi's new long-term Lemtrada data amp up sales in a crowded MS field?
Can Sanofi's new long-term Lemtrada data amp up sales in a crowded MS field?
Fierce Pharma
Sanofi
Lemtrada
MS
multiple sclerosis
Flag link:
Evotec and Sanofi Join to Further Cutting-Edge Therapeutic Drug Discovery
Evotec and Sanofi Join to Further Cutting-Edge Therapeutic Drug Discovery
BioSpace
Sanofi
Evotex
drug development
LAB031
Flag link:
Vaxart Stock Soars on Oral Flu Vaccine Results
Vaxart Stock Soars on Oral Flu Vaccine Results
CP Wire
Vaxart
flu vaccines
Sanofi
Flag link:
Vaxart Stock Soars on Oral Flu Vaccine Results
Vaxart
flu vaccines
Sanofi
Flag link:
Recipharm acquires Sanofi inhalation contract manufacturing business
Recipharm acquires Sanofi inhalation contract manufacturing business
Pharmaceutical Business Review
Recipharm
Sanofi
drug manufacturing
contract drug manufacturing
inhalation drugs
Flag link:
Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug
Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug
Bloomberg
Regeneron
Sanofi
Libtayo
immuno-oncology
skin cancer
FDA
Flag link:

Pages